drugset / Trial / NCT05504876
Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114
NaSingle-groupOpen-labelTreatment
Summary
This is a single center, open-label study to investigate whether HEC74647 and HEC110114 has an effect on the pharmacokinetic (PK) profile of midazolam（a cytochrome (CYP) 3A4 substrate）in healthy subjects
Timeline
- Start
- 2022-11-07
- Primary completion
- 2022-12-13
- Completion
- 2022-12-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HEC110114 | Unknown | 600 mg | Oral |
| Subject | HEC74647PA | Unknown | 100 mg | Oral |
| Subject | Midazolam Syrup | Unknown | 5 mg | Oral |
Indications
No indication recorded.